Antiphospholipid syndrome (APS) is an autoimmune condition characterized by hypercoagulability often manifested as recurrent thrombosis or pregnancy complications, with persistently circulating antiphospholipid (aPL) antibodies or lupus anticoagulant. Catastrophic APS (CAPS), also known as Asherson syndrome, occurs in less than 1% of cases of APS and involves occlusive microangiopathy in at least three organ systems.1 Case…
It has been nearly 35 years since the original descriptions of what now is recognized as AIDS (the acquired immune deficiency syndrome), an advanced form of infection secondary to the human immunodeficiency virus (HIV). The epidemic of HIV infection remains the singular most dramatic epidemic of our generation and will likely remain with us for…
Editor’s note: This is the first installment of a two-part series showing how a busy office-based practice can incorporate patient advocacy into its standard workflow. Part 1 outlines the reasons for advocacy and the benefits to both patients and doctors, then gives a quick-start outline to get you started. Part 2 will amplify the concepts…
The pathogenesis of and new classification criteria for MAS
A profile of individuals recognized for advancing rheumatology advocacy, service, education, patient care
NIAMS director Stephen I. Katz, MD, PhD, highlights agency research, training planned for this year and beyond
How practicing clinicians can generate interest in rheumatology among medical students
Patient histories, clinician reports of condition also called Köhlmeier-Degos disease underscore need for integrated, multidisciplinary care
Awards, appointments, and announcements in the world of rheumatology
Awards, appointments, and announcements in the world of rheumatology